Vanda Pharmaceuticals (VNDA) Intangibles (2016 - 2025)
Vanda Pharmaceuticals (VNDA) has disclosed Intangibles for 16 consecutive years, with $117.1 million as the latest value for Q4 2025.
- Quarterly Intangibles rose 2.62% to $117.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $117.1 million through Dec 2025, up 2.62% year-over-year, with the annual reading at $117.1 million for FY2025, 2.62% up from the prior year.
- Intangibles hit $117.1 million in Q4 2025 for Vanda Pharmaceuticals, up from $108.8 million in the prior quarter.
- In the past five years, Intangibles ranged from a high of $121.4 million in Q4 2023 to a low of $17.4 million in Q3 2023.
- Historically, Intangibles has averaged $62.5 million across 5 years, with a median of $21.0 million in 2021.
- Biggest five-year swings in Intangibles: fell 8.0% in 2023 and later skyrocketed 564.72% in 2024.
- Year by year, Intangibles stood at $20.1 million in 2021, then fell by 7.55% to $18.6 million in 2022, then surged by 553.75% to $121.4 million in 2023, then dropped by 5.99% to $114.1 million in 2024, then increased by 2.62% to $117.1 million in 2025.
- Business Quant data shows Intangibles for VNDA at $117.1 million in Q4 2025, $108.8 million in Q3 2025, and $110.6 million in Q2 2025.